It’s Hard for Doctors to Unlearn Things. That’s Costly for All of Us.

It’s Hard for Doctors to Unlearn Things. That’s Costly for All of Us.

  • September 15, 2018
Table of Contents

It’s Hard for Doctors to Unlearn Things. That’s Costly for All of Us.

Procedures live on even after they’ve been proved ineffective. It can lead to harms and wasted resources. Part of a doctor’s tool kit is learning new things, but also unlearning some things.

The second part may be harder than the first. We know it can be hard to persuade physicians to do some things that have proven benefits, such as monitor blood pressure or keep patients on anticoagulants. But it might be even harder to get them to stop doing things.

In May, a systematic review in JAMA Pediatrics looked at the medical literature related to overuse in pediatric care published in 2016. The articles were ranked by the quality of methods; the magnitude of potential harm to patients from overuse; and the potential number of children that might be harmed. In 2016 alone, studies were published that showed that we still recommend that children consume commercial rehydration drinks (like Pedialyte), which cost more, when their drink of choice would do.

We give antidepressants to children too often. We induce deliveries too early, instead of waiting for labor to kick in naturally, which is associated with developmental issues in children born that way. We get X-rays of ankles looking for injuries we almost never find.

And although there’s almost no evidence that hydrolyzed formulas do anything to prevent allergic or autoimmune disease, they’re still recommended in many guidelines.

Source: nytimes.com

Share :
comments powered by Disqus

Related Posts

Researchers Identify Molecule With Anti-Aging Effects On Vascular System

Researchers Identify Molecule With Anti-Aging Effects On Vascular System

A molecule produced during fasting or calorie restriction has anti-aging effects on the vascular system, which could reduce the occurrence and severity of human diseases related to blood vessels, such as cardiovascular disease, according to a study led by Georgia State University. In this study, the research team explores the link between calorie restriction (eating less or fasting) and delaying aging, which is unknown and has been poorly studied. The findings are published in the journal Molecular Cell.

Read More
The inconvenient truth about cancer and mobile phones

The inconvenient truth about cancer and mobile phones

On 28 March this year, the scientific peer review of a landmark United States government study concluded that there is “clear evidence” that radiation from mobile phones causes cancer, specifically, a heart tissue cancer in rats that is too rare to be explained as random occurrence. Eleven independent scientists spent three days at Research Triangle Park, North Carolina, discussing the study, which was done by the National Toxicology Program of the US Department of Health and Human Services and ranks among the largest conducted of the health effects of mobile phone radiation. NTP scientists had exposed thousands of rats and mice (whose biological similarities to humans make them useful indicators of human health risks) to doses of radiation equivalent to an average mobile user’s lifetime exposure.

Read More
AI System Approved For Diabetic Retinopathy Diagnosis

AI System Approved For Diabetic Retinopathy Diagnosis

A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices. Results of that study were published Aug. 28 online in Nature Digital Medicine, offering the first look at data that led to FDA clearance for IDx-DR, the first medical device that uses AI for the autonomous detection of diabetic retinopathy. The clinical trial, which also was the first study to prospectively assess the safety of an autonomous AI system in patient care, compared the performance of IDx-DR to the gold standard diagnostic for diabetic retinopathy, which is the leading cause of vision loss in adults and one of the most severe complications for the 30.3 million Americans living with diabetes.

Read More